Professor of Surgery, Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine, Atlanta, USA
Dr. Staley joined the Emory faculty in 1995 after completing a surgical oncology fellowship at MD Anderson Cancer Center. His clinical practice focuses on treating rare and difficult cancers of such organs as the pancreas and liver. With research interests encompassing translational research and novel clinical trials in gastrointestinal cancers, Dr. Staley has investigated gene therapy for metastatic colon cancer, radiofrequency ablation with intra-arterial chemotherapy for patients with colorectal liver metastases, and neoadjuvant chemoradiation with the goal of maximizing sphincter preservation in the treatment of rectal cancer.
His main research interest: gene therapy for metastatic colon cancer, radiofrequency ablation with intra-arterial chemotherapy for patients with colorectal liver metastases.
Medicinal Chemistry received 6627 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 